Fundz

Cellestial Health raises pre-seed funding led by Zinc VC to advance its astrocyte-targeted drug development for brain disorders.

PRIVATEMay 09, 2025

Round Type

Pre-Seed

CambridgeBiotechnologyHealth CareTherapeutics

Investors

SFC CapitalAlma AngelsZinc VC

Description

Cellestial Health has successfully raised pre-seed funding, led by Zinc VC and supported by SFC Capital and Angel investors. The funding will help develop innovative treatments targeting astrocytes for neurodegenerative diseases. Additionally, the company received £340k in grant funding from Parkinson’s UK and Cambridge Enterprise. Their approach seeks to revolutionize brain disorder treatments by restoring normal astrocytic functions.

Quick answer

Cellestial Health raised an undisclosed amount in a Pre-Seed round, dated May 9, 2025. Investors: SFC Capital, Alma Angels and Zinc VC. Cellestial Health is based in Cambridge, England, United Kingdom.

How much did Cellestial Health raise?
Cellestial Health raised an undisclosed amount in a Pre-Seed round on May 9, 2025.
Who invested in Cellestial Health?
SFC Capital, Alma Angels and Zinc VC are named as investors in this round.
What does Cellestial Health do?
Cellestial Health is focused on revolutionizing the treatment of brain disorders by incorporating astrocytes into drug development.
Where is Cellestial Health based and how big is it?
Cellestial Health is based in Cambridge, England, United Kingdom. Fundz records about 4 employees.
Who are the decision-makers at Cellestial Health?
Fundz holds 1 contact at Cellestial Health. Names and contact details are shown to Fundz members.

Source: Fundz verified event record.

Who else raised in Therapeutics and Biotechnology around the same time

Companies in the same sectors as Cellestial Health that raised within 45 days of this round, from Fundz verified event records.

  • Os Therapies raised $4.2M on June 23, 2025.
  • Actio Biosciences raised $66M (Series B) on June 18, 2025.
  • Arialys Therapeutics raised $15M on June 13, 2025.
  • Canton Strategic Holdings, Inc. raised $2.5M (Seed) on June 13, 2025.
  • ADC Therapeutics raised $100M (Private Equity) on June 12, 2025.
  • Ensho Therapeutics raised $23M on June 12, 2025.

Who to call at Cellestial Health, and when

A new round usually means Cellestial Health is about to hire and buy. The teams that reach out first get the meeting.

  • An alert the day Cellestial Health raises, hires an executive or expands, scored against what you sell
  • The decision-makers there, with verified emails
  • Who you already know at Cellestial Health, from your own LinkedIn network

Works inside ChatGPT and Claude. Ask who to call at Cellestial Health. With Fundz connected, it knows.

Watch Fundz in
See plan options
Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce 4.8/5 on G2

Company Information

Company

Cellestial Health

Location

Cambridge, England, United Kingdom

About

Cellestial Health is focused on revolutionizing the treatment of brain disorders by incorporating astrocytes into drug development. The company aims to develop brain-permeable small molecule drugs that restore normal astrocytic network function, offering a new pathway for neurodegenerative conditions like Parkinson's disease. Built on years of academic research, Cellestial validates its drug targets and collaborates with leading drug discovery experts to advance its innovative therapeutics. Their mission addresses the urgent need for treatments that go beyond symptom management in neurodegenerative diseases.

AI made execution free. Knowing first is the whole game now.

Fundz sees it the moment Cellestial Health raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.

Related People

1 contact
Predictive Intelligence
Strategic

ML-powered predictions for Cellestial Health's next move

See what Strategic adds

Cellestial Health raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.

145 of these a day, filtered to the companies you pick, with the decision-maker attached.

5 screens from a live account. No signup.

Fundz is a real-time business intelligence platform powered by agentic AI that proactively delivers personalized daily signals, including funding rounds, executive changes, M&A activity, 13F institutional filings, SEC 8-K events, investor activity, and website modifications, based on each user's watchlist and ICP. A trusted data source at firms such as BlackRock, Oracle, Kleiner Perkins, LinkedIn, HubSpot, and Cloudflare, Fundz democratizes the institutional-grade intelligence that previously required a PitchBook or Bloomberg terminal. Features include Daily Briefing for AI-powered daily briefings, and unified cross-signal alerts across 281,000+ organizations. Developers and data teams can access these signals programmatically via the Fundz Funding Data API, with transparent published pricing.